Michael Wilson - 30 Jun 2025 Form 4 Insider Report for CELESTICA INC (CLS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jul 2025, 16:28:43 UTC
Prior SEC filing
10 Jun 2025
Next SEC filing
15 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tracy Connelly McGilley, attorney-in-fact

Key filing fact

Michael Wilson filed Form 4 for CELESTICA INC (CLS) on 01 Jul 2025.

Key facts

  • This page summarizes Michael Wilson's Form 4 filing for CELESTICA INC (CLS).
  • 5 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 01 Jul 2025, 16:28.

Change

  • Previous filing in this sequence was filed on 10 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001868238 Primary reporting owner

Wilson Michael

Relationship
Director
Address
5140 YONGE STREET, SUITE 1900, TORONTO, ONTARIO, CANADA
Signature
/s/ Tracy Connelly McGilley, attorney-in-fact
Signature date
01 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLS transaction

Common Shares

Options Exercise

Transaction value
$0
Shares
+5,890
Change %
+79%
Price
$0.000000
Shares after
13,391
Date
30 Jun 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLS transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-3,149
Change %
-100%
Price
$0.000000
Shares after
0
Date
30 Jun 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
3,149
Exercise price
Footnotes
F1, F2
CLS transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-2,145
Change %
-50%
Price
$0.000000
Shares after
2,146
Date
30 Jun 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
2,145
Exercise price
Footnotes
F1, F3
CLS transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-596
Change %
-33%
Price
$0.000000
Shares after
1,191
Date
30 Jun 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
596
Exercise price
Footnotes
F1, F4
CLS transaction Derivative

Director Share Units

Award

Transaction value
$0
Shares
+671
Change %
Price
$0.000000
Shares after
671
Date
30 Jun 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
671
Exercise price
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.

Footnote F2

On June 30, 2022, the reporting person was granted 9,448 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Footnote F3

On June 30, 2023, the reporting person was granted 6,437 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Footnote F4

On June 30, 2024, the reporting person was granted 1,787 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Footnote F5

Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .